Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like I said, impossible to have a counter argument in that. Pretend to ignore. Great call!!! May have missed a period. Whew. Don’t want to get called out on that
Sorry that’s not transparency whatsoever. Now Tobias. Wow. Probably responsible for our stock not cratering. He’s joining our IR team I hope. How’s the weather in China? LMBO
Assumptions is all anyone can go on. It’s what our twins are best at. Zero transparency whatsoever. Zero guidance at all. Missed milestone after missed milestone. Like nothing I have ever seen. All signs of great management, and makes potential investors in a dilution, not need a substantial discount to take the plunge and take a risk on these incredible business leaders.
But way to tear my argument apart with any kind of factual counterpoints. Or any opinionated arguments at all. I see why you follow Allo and Zzatt. Full of “hope”. At least Zzatt pretends not to read my posts, as countering is a pretty difficult task. Remember always. We got SCIENTISTS...and Tobias. Repeat repeat repeat. Oh and your sharts seem to agree with my plausible opinions, that used FACTS to help back them up
But but but...their presentation said $27 million in grants.
Keep on following them. You’re well on your way to being in their boat. Congrats. As long as there’s no bad news and Tobias keeps throwing out some quotable phrases, that’s good enough for me. I’m a BELIEBER and a follower!!! Who cares how this gets funded until we get an approval. Didn’t you hear, we got more scientists!!! We WIN!!!
All is well...All is well
Let’s again, take a look at their financials.
June 30/18
Cash and equivalents. $32 mil
Liabilities. $8.5 mil
Leaves them with $23.5 left.
Now in their last report, in the last 3 years they have used approximately $9.9 mil of their grants from Horizon and IIA. They were directly receiving $6.4 million from the Horizon,
Grants.
$6.4 million direct from Horizon
$3.3 mil IIA 2016
$1.4 mil IIA 2017
$900 g’s IIA 2018
$11.6 million total.
Anyone see a pattern to the size of the IIA grants?
That leaves them with $1.7 mil left via grants.
They have a grand total of approximately $25.2 left as of June 30th. And yes a quarter has passed, so maybe bring that down to around $20 mil. With grant money most likely gone already, quarterly cash used will be rising.
They’re going to need cash in the very near future. Could be down to $15 mil by eoy. What impact will that have on the share price?
Keep selling via the ATM? Do they want to add more pressure on the price? What will that do to the size and proceeds of the dilution if/when they pull that trigger?
Quite the predicament for our “experienced” twins. But they “got this”. Never had a problem finding investors to shaft in the past with their raises before. Getting funding is easy, free shares and big raises for the lucky few at the top. Well deserved.
A stockpiling contract would obviously help, but that seems to be less likely with each passing quarter. The delay in just getting the pivotal ARS study going is telling.
Why the sudden change of heart with our in house manufacturing prowess? Thermo collaboration is most likely to see if Thermo can benefit from Pluristem’s technology. That’s why terms will be discussed later imo. If Thermo does find a use, could give the company some cash. But with an imminent stockpiling agreement to occur by the end of 2017, why now, after more than a decade of keeping it all to ourselves.
But shareholders don’t deserve to know what’s going on at all. Just keep us informed with the same presentation time and time again. Take out the milestones to try and save face.
Why inform them of enrolment numbers for their trial. There was a reason for that during the IC trials. Recruitment was agonizingly slow. But CLI will be different. Should be halfway through our trials by now right.
Pretend not to read anything beyond the first couple sentences. Pretend you couldn’t make out the “gibberish”. Look for a misplaced comma though, or a typo. That keeps “hopes” alive, when reality says otherwise.
Once ROctober’s done, we still have NoNovember and DUDecember left to truly make 2017 errr 2018 “THE YEAR OF THE SHAREHOLDER”. As Rocking Zami walks in to the board meeting, both hands raised with the sign of the horns, as board members slurp back matzah ball soup and toast with a glass of Cristal.
And you really have to delve deeply into charts and technicals to come to these conclusions? You come to these “conclusions” yet you’re going to hold and wait? What’s the point of wasting so much time on it and NOT putting faith in what they’re telling you? “Charts don’t lie” right. You have criticized others for buying and holding all the way down and yet you seem to be doing the same thing. All this as their stock is within a penny or two of their 52 week low. Welcome to the world of gambling on a stock like Pluristem. Buy at pretty much any price and watch it erode.
That’s what we need now is a “blowout piece of news” to get us above $1.20. Yikes. We are in trouble.
Being a non-shartist, I will also make the call of a lower price with no news, and a higher one with. And the bigger the news, the bigger the jump. Or if bad news comes out, we will go down faster. I for one, just like to go out on a limb sometimes. All without the help of a shart.
Too funny. Zami could probably change the ink cartridge though. He is an engineer after all. But then again, thy my be beneath him now. Maybe another job position could open up. A CCT. Carbon Cartridge Technician. Entice them with free shares.
But don’t forget about Shemp. Maybe Egozi can fill that role. Nyuk nyuk nyuk.
I must admit, you are an eternal optimist. A real stalwart for this company and management. Wish I could be. Kudos and keep it up. And my apologies, I thought it was 10k shares, not $10k. Your probably are down just minimally. Sorry for mistake on my end. ;)
Post 7754 Oct 30/17 Price High $1.75 Low $1.63
A combination of new funds (shelf) AND a strong forward momentum
in moving PAD/PLX toward commercialization is positive. There may
be a few days of downward pressure on the pps, but I've seen that
reverse very quickly.
The important thing is for management to provide guidance as to
how the money will be used to advance the cause. I'm not worried
at this time.
Yes there is, I'm in the process of buying a few multiples of $10K !!
Sorry but that’s the only logiclcal explanation as to why they haven’t got a contract yet. Injection device...Arik’s second jobs got that. Stole it right under the nose of Lonza, who wasted all that money opening right next door to them. Behemoth of a blunder from Lonza’s management. ICan’t produce enough. Thermos to the rescue. Abstract hidden from view. Only to be revealed once the big deal is done. Top secret is all that’s left. Tea leaves are locked and loaded, ready for a huge NoNovember!!!
DOD wants everything under wraps. DOD is in obviously in control of everything. Pluristem can’t refill the ink on the printer without their consent. Didn't want a mob on BARDA day, so they told them they’re not allowed to go. Everyone can only talk about them, in the hopes Zami will make a rock star type of appearance so the crowd can go wild. Keep em in your tops ladies. Contract must be imminent. Like the sharts, she’s ready to explode.
ROctober’s time is quickly running out. Will it be followed by a NoNovember. We will see what the sharts say in early December.
Hey EichKing,
That’s the trouble with baby stocks like Pluristem. Sharts can be all over the place. I wanted to see if it can be a helpful tool to predict the trends in price though.
So I’ve been investigating Bollinger Bands,resistance, double bottoms, rounding bottoms, and even some basic financial terms to see how they can influence the sharts.
Bollinger Bands are like a containment zone for the sharts. In case momentum builds or turns negative, it will help relax or run before it happens.
Double bottoms are another tool for the shartist. A retesting of sorts, to see if it can hold. Often difficult, but great to see. It held again.
Not to be outdone is a rounding bottom. It’s when you think things could blow, a slow , gentle relief begins until the trend reverses.
And of course the back and fill. Just when you think things are going good, something changes. The movement down surprises the shartist. Luckily there is enough room to hold, and it fills, awaiting another breakout.
Now I’d like to see if there’s any correlation to the sharts, and the basic supply and depends side of the equation. Let’s say XYZ company is selling wedgies. If the depends side dries up, what effect could we see on the sharts? Profits could go down putting tremendous pressure on the shart. A short squeeze could alleviate the downward pressure a little, bit unlikely, considering the momentum is all out of gas. Then all hell could break loose.
This world of sharts sure seems complicated. Schooling would probably be best. A class maybe, to see if sharting is something you want to pursue. Get a degree in sharts if it’s your cup of tea. Maybe become a master sharter if you enjoy it. Heck even become a Dr. of sharts. Help speed the word and show your love of sharts.
Not for me. I’ll leave it to the pros. Hard to compete with a master sharter.
Sorry there was no call on a move to $1.38. No mention of the high $1.30’s anywhere. PLEASE prove me wrong and point me to the post number. Your call was for the high $1.40’s to low $1.50s. You didn’t even make it half way to your call. And I’m supposed to think it was impressive? It wasn’t. Anyone else can chime in if they thought it was.
Below I have outlined all of your “calls”. You want to try and find one that’s correct, be my guest. Guarantee you won’t find one. I’ve left out the dozen or so calls of the quick drop to $1 to $1.10’s, even to $.75. Already proved that one. Hey if we even make it there next week I’ll throw it in as your first one for the win column. But again, not that impressive as that’s where we will most likely end up with no news with teeth. Don’t need charts to see that potential.
Your latest call doesn’t count. We break through $1.20 and have stayed there for a week. Now you think a call of resistance at $1.20 is some amazing insight. Did you have to actually look at a chart to see that? Or could pretty much anyone with any sort of basic knowledge of the market see that. When did you make that one Wednesday.
So you tasked me to look for myself so I did and heres my report back to you. Didn’t think I would. It was a lot of posts to look at that’s for sure. But if you look back on all my posts regarding all of our upper management and board, you’ll see I’m pretty thorough.
All factual, all quoting you directly. Honestly I don’t know how you even look at charts anymore. You can pretend not to read all of my post if you like. Heck let anyone try to stand up for your calls or find a correct one for themselves.
Tell you what. If you or anyone else finds a correct call I won’t post for at least 6 months. I’m not talking “base forming” or “accumulation”. More like the ones below. These are all I found. But you did get 2 calls correct and I’ll show you at the end. They were only correct as you left the charts out of the equation, and before the kool aid.
Post 15113. Aug 22 after close
“In the meanwhile enjoy the ride which I measure into the high $1.40's maybe low $1.50's”
We closed at $1.32 that day. Touched $1.38 but closed no higher than $1.37 for the next few days. Then the downfall to where we are today.
Post 13150 June 28.
“I'll say this, if you own it, hold it but now is not the time to buy it. It has and will go lower IMO”
Closed $1.21. You made that call at the exact low. Ten trading days later we closed at $1.30 and didn’t get back to $1.21 until October.
Post 15078 Aug 21. “Added a little to my position at $1.295. Liking what I'm seeing so far.”
That’s the entire post. No high $1.30’s call made at all. But now, the two you were correct with.
Post 14371 July 30
“That tells me my 1st purchase was not properly thought through. But if there's a second purchase the market will tell; me not the wonderful possibilities that it will or when it will. “
Feel free to add the second purchase to that group if you like.
Post 13825. July 19
“Seems I'm not the only one questioning the credibility of the of the mgmt. The market apparently has a huge problem with it as well”
Don’t give up hope though. Your call of the $1 to $1.10 or even down to $.75 could still come through. Odds are in your favour. One things for sure on that call...you have a couple of twins who are quite qualified to make it happen. It’s what they’re great at.
I must admit the call was pretty close. Wonder why they didn’t want to provide an actual post where they say that stunner of a call, yet tell me to find it. Convenient how they left out some info. Post 15113 from Aug 22nd states “In the meanwhile enjoy the ride which I measure into the high $1.40's maybe low $1.50's”. Did we get anywhere near there and I missed all the fun? Highest we got was $1.38 intraday since then, all the way to where we sit today.
Wonder if they capitalized on that nibble for the big 5% gain, or now down 8% on that snack? And was it enjoyable?
Frequent flyer perks for events. One more year and they get toilet paper with their logo on it to throw out to the 10 in attendance.
Heard Thermo beat them out. Frantic negotiations, counter bids, midnight sessions. All to be determined in the future. That’s what BARDA wanted so I’ve heard. Once moonlighter Arik invents the new injector, it will be all systems go.
It’s truly TOO EASY!!!
Cmon now, they stated it’s not an exact science. How science even enters the equation on a stock like this is beyond me. “Charts see the news beforehand”. But somehow they didn’t see that one to stop the quick drop in his many predictions. Resistance now turns to the upside. Muuusssstttt get throuuuuggghhhh $1.20 noooowwww. Accumulation, solid base, breakout coming. Look out below... What’s the flavour today? I’ll let you know after close.
Look at the 2 year chart. Shows exactly where you could have made some dough. I guess zome just like being down “minimally”. As long as Tobias continues to give quotable statements. Heck just keep quoting the couple out there over and over again. Quick enough for ya? LMBO
There it is. World tour has begun!!! I was wondering why 180 employees couldn’t handle the EAP. Solved. Employees now bustling getting flights booked, searching for best hotels, car rentals, restaurants. Employees were getting worried as it was a little late this year. All they had was their free shares. Then big Zami boosts morale again. Exotic locations reserved for the upper management, with leftovers going to best brown noser.
Go Fonzie!!!
And like I said, your technical prowess would have gotten you in and out perfectly. Would have seen all those positive releases, great volume, and knew it was a pump to sucker in the Israeli investors. Charts know it!!!I’ll stick with Allo’s tea leaves. About as accurate. See you couldn’t provide a post where your “analysis” came through.
I brought up that breaking of the $1.20 mark since you mentioned it quite frequently. Then the news of them “partnering” with a startup kept the price above your quick downfall prediction. How did you know that? Something now in the past happened and now you use it to justify why your original call didn’t happen. An excuse in reality. Thought charts see news in advance. Isn’t that what you said? You kinda made my point.
Pull up their 5 year. Started at $3.29. Quite the haircut. We have progressed further in those 5 years. Two phase 3’s right? All great data so far right? Potential stockpiling for ARS no? Why the 5 year spiral down. There’s got to be some other reason for this never ending decline in price don’t you think. I guess markets don’t care until approval. No stocks ever move up until then. In fact, the farther you progress through trials, the less people are willing to pay. Phase 3 stocks are riskier than 1 or 2 most likely. Makes sense don’t you think?
See you leave out any other things I mentioned. Funny others do the same here too. Management is irrelevant I guess. Anyone can run a company in this space. Experience...unnecessary. Connections...irrelevant. Selling vision systems to the textile industry or the simple process of navigating the easy world of FDA approvals in a brand new field of medicine...identical. Competition...sits still when you have “in house” manufacturing. Scares companies away from the potential billions and billions to be made.
Like I’ve said in the past. All these new fast track, priority reviews, breakthrough therapy, accelerated approval, etc that have come into play, only equal the playing field for the big guys in this space. Celularity, the one people dismiss, are expecting results next month for their phase 2 diabetic foot ulcer. The trial that will measure all the outcomes and more than our current cli does. You know, the company that raised $250 mil in a heartbeat. Using placental cells. The ones who have more parents than us. A company that is located in the same country as the FDA and the biggest market in the world. Experienced, well connected management team. No worries. We got twin CEO’s.
What’s going to happen if no partnership with $$$ or stockpiling occurs. How are they going to do a raise, especially after shaving the last ones. That’s why the ATM has been picking up. It’s their only way of trying to cash reserves from dwindling to a point where their cash saving emergency plan kicks in. Guess they could issue a ton more shares at another big discount. See if there’s any suckers left. Then give them the ultimate shaft via a r/s
Or they can partner. They’ve only been saying that for a decade maybe. Japanes partner was supposed to happen in 2016. Any day now. Few years ago they stated they’re going to partner with phase 2 products. Any day for that as well.
Their options are limited. Very. That’s why this thing with Thermo is happening imo. Plan D.
Won’t even go into hct and all the trials further ahead. We’ve been waiting almost a year over their estimate as to when we will see interim results. Started Feb 2017 and enrolling 24 patients. Twenty Four!!! Everyone was so excited when they expanded to Israeli sites. “Must be going great to expand into Israel”. “Everyone wants in”. More like they can’t get anything done with any sort of efficiency. Just look at the IC trial for proof. Or HCT, ARS, NYBC...
But outsource the EAP to a startup. We only have approximately 180 employees. World tour take up too much of their time? In the business now for how many years? Nobody in house have any experience in this field or what? We are a biotech company are we not? But like I said, anything out of their hands is better.
I, like EichKing, have been in this company a long long time. I was lucky enough to sell my shares out of necessity at a small profit. Small being the key word. But didn’t want to risk missing some sort of miracle buy out, partner, stockpiling contract. So I just buy cheap options as far out as I can. Now only with proceeds from other trades I make. Will continue to until they make it, or die. This stock is nothing more than a gamble, with decreasing odds as each quarter passes. But Im a gambler sometimes. As any long timer here will tell you, management has misled their shareholders by giving them truly fictitious milestones, expectations, progress reports etc. Another sign of good, experienced management. Especially in the new and improved “year of the shareholder”. They moved it in 2017 to 2018, so expect another move come the end of the year. All while they continue to gift themselves free shares.
Like I said, nada. Don’t need to learn “technicals” for this stock. Waste of time.
Go have a look at all the posts I have made about our leadership and their many gaffs. Our joke of a board. Just have a look at who is running this company and their resumes. Look at the board members resumes. One thing that’s missing from pretty much ALL of them is any sort of pharmaceutical experience. Experience as CEO of two bit companies, most defunct, with little to no information on them.
Have a look at shareholder updates for the last 3 years. Jokes. Zero information. Zami’s infamous quote “we made most milestones”. We get our information via presentations. Wow. And now they change them every few months at best. Last ones from July. Now no milestones at all. Just go with the flow and hope for the best. That’s probably what all great leaders do.
Go have a look at our Companies cc’s after each quarter. Oh ya, they don’t do them. Many of their news releases are vague at best, leaving shareholders to guess what they mean. Collaboration, partner, now strategic partner in an interview. 16 months since ARS dosing trial. Milestone of 2h17 for a stockpiling agreement. Yet can’t even get the pivotal trial started. Why? Who knows. Shareholders are left in the dark.
What’s going on with Sosei. Still rears it’s ugly head in every quarterly report. Only been what, 2 years. Japanese IC trial design given the go ahead in December of 2015!!! You know, the one that’s fast tracked. We see the older Japanese man in every presentation. Waving his fist at someone. BINDING term sheet with China company. Failed. No idea what binding means I guess.
I mentioned the whole manufacturing fiasco the other day. Wonder how much was spent building, expanding, maintaining, leasing all that space has bought us. How many doses have they made in all the years it’s been operational? A thousand? Good old smug Zami used to brag about our manufacturing abilities. “The pricess is the product”. Now that 3D bioreactors and others are around, what did that buy us. Easily scaleable...just add more bioreactors so we thought. Now we must collaborate with another manufacturer.
They thought they had all the time in the world. Zami himself stated they lost TWO years development time building our manufacturing. Great call don’t you think.
Others here seem to think we are the leaders in many of our trials, just like Zami and company do. Many others right there or passed us, or soon will. Many here dismiss the competition. We compete against many 800 pound gorillas. Ones with deep pockets, vast experience, and connections everywhere. We got our engineer and accountant co-leading our way.
How about the ATM they’ve been utilizing. Quite a bit more last quarter. Nothing like a company selling into any run we muster.
Kind of makes you wonder who in this world would believe anything these guys say. Or makes you understand how we tend to go down on any release we put out there, with zero run up into it. And most of all, why we are sitting at $1.20 when we have this “incredible” technology. Pretty hard to find any chart where we are actually up. Definitely have to customize that one...or give the daily chart, once every week or so.
Would love to hear your thought on any of this. Or are you strictly technical?
Mr. Doron Shorrer (CPA, Israel) was Chairman of the Board of Phoenix Insurance Company, one of the largest insurance companies in Israel and Mivtachim Pension Benefit Group, the largest pension fund in Israel, managing $15 billion. Before assuming these positions, Mr. Shorrer held senior appointments that included: Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the Board of Directors of "Nechasim" of the State of Israel; Member of the Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Co-Founder and Director of an accounting firm having three branches (Jerusalem, Tel-Aviv, Haifa); Member of the Lecture Staff of the Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy. Among many areas of expertise, Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector. Additionally, Mr. Shorrer consults on economic, accounting and taxation issues to a large audience, ranging from private concerns to government ministries. Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration, with a specialization in finance and banking from the Hebrew University of Jerusalem. He is a Certified Public Accountant (ISR).
Wonder why Menora Mivtachim Holdings unloaded their entire million shares? Right in Pluristem’s backyard. An Israeli insurance company too. Doesn’t one of the geezers on our board have insurance connections too?
https://fintel.io/so/us/psti
Hey Hopester,
Since you joined this board, you have stated at least a dozen times if we break $1.20, it will be a quick drop to the $1-$1.10’s, and possibly to the .75 range. (Posts 14736, 13094, 13813, 14575,16541 among others)
We’ve closed below it for 6 days now. You have kept your original shares, and even nibbled and bought a little more on one of our “up” trends. You would think you would have unloaded as soon as we crossed that $1.20 mark, as you would be able to get back in cheaper no? Or what’s the point of making such claims. Charts are pretty accurate right? Or is it but and hold in the hopes of something now. Can’t keep it straight.
But now today we must break above $1.20 resistance. What happened to our quick descent?
July 21, indicators were pointing up. (Post 13941). Sitting at $1.30. Drifted down to the mid $1.20’s for 3 weeks.
June 12 Post 12802. “That makes $1.30 a giveaway”. Drifted lower for nearly a month.
Now when I say to you lucky you weren’t in on dday last year, you show me a 2 year chart saying it was clearly overbought. That run up would have blown through all your technical data, on solid news, with great volume. You claim you don’t mind buying at higher prices, but magically you would have seen they were overbought, stayed away or sold, and would have gotten out before the dilution that slammed the stock.
But yet you try to claim voodoo metrics for Eich’s penny guessing accuracy a vast majority of the time. Don’t imagine he thinks it brings any edge as to when to get in or out, but being in a his company does allow for some pretty accurate calls...all without charts.
Dismiss him as you wish. After dday, he called where we would be with outstanding accuracy. Even though zome, who had “seen a climb back before” after a dilution event, were loading up with a 30k purchase in the $1.60’s right after the event. To bad zome didn’t listen. Doesn’t matter, they’re still Happy.
You’re charts just change day to day based on the past. Inaccurate and basically useless with a stock like this. Claim the charts always see the news ahead of time. Absolute joke. Sure we might see a significant uptick in volume and price an hour or two, or even the whole day before close. But we’ve seen that a million times only to be back down even lower, with dried up volume again.
I’m sorry but there’s no way your charts can predict any news that could inevitably move this stock in a big way either good or bad. A $50 million contract for ARS could shoot us up to $2 or $3 in a day, or a failed trial or adverse event could throw us down by more than a half in a heartbeat. All too late to do anything.
So keep calling it voodoo metrics. You’re predictions are pretty much useless. You’re down on Pluristem right? But like you said, “they haven’t let you down so far”. Charts might as well originate in Haiti on a stock like this.
Go Fonzie!!!
Not much to be found on Widetrial. A startup late last year. Couldn’t find any other companies using their services. At least these guys have some experience behind them. And anything out of the hands of our twins, the higher chance of success. Even at $20k a treatment, we’re looking at $2 mil. Highly doubt they would get that price in this type of situation, but who knows.
https://www.bizjournals.com/sanfrancisco/news/2018/05/31/this-man-proposes-a-win-win-for-patients-pharma.html
Just another baby step. Or an embryonic squirm. Nothing to eat words about, that’s for sure. Maybe a couple hundred g’s in the companies pockets via the ATM. Like Zzatt says, safety with a little efficacy should be enough for FDA approval. So what’s the criteria for EAP. Anyone know of some good placebo manufacturers? With some slight placebo effect improvements that can be found in many studies, I’m expecting a dramatic increase in placebo approvals from the FDA.
Go Tobias!!!
Don’t worry. We all know who he is. But granted most don’t have a pic of him as a screensaver like zome do!!! LMBO
Since you’re all about “facts” there Hopester, you didn’t do what Blue asked you to do in your insider trade claims in post 15206. 910,000 insider buys in the last year. What a joke. Doubt that number is even close to a third for the lifetime of this company. Why buy when you can gift them to yourself year after year, for over a decade. I heard that could become their new company mission statement.
I’ll do you a favour and give you a link. Please get back to the board on what you find. At least it shows why you let charts guide you. DD evades some.
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001158780&type=&dateb=&owner=only&count=40
Thanks Auto. It’s just too easy. But but but...they got thesaurus boy.
Where oh where did you find a 2 year chart. Great find. I’m going to try and find all the highs and lows from the last 2 years now. Show me exactly where I should have bought and sold. What an incredible tool. I’ll be locked and loaded for when they invent a time machine. Who cares who runs this company. We got charts!!! And Tobias on our side!!! That’s proof enough for me. A nods as good as a wink to a blind bat.
But please advise me when I should start eating my words. If we hold up 6 cents off our 52 week low? Or approximately 25 cents down from the start of your chart. A 2 year chart. Wow!!! What will they think of next...a 5 year!!!
You’re the one who stated it was overbought then right? I asked you to show me the beloved chart that showed that. You didn’t, you can’t. Don’t throw voodoo statements out there you cant back up. Great job.
Just like all the others. Go figure. Acumen. A favorite word from someone else. You have a hankering for Tobias too.
Wow your charts work great in hindsight. Overbought shown a year later. Amazing. No voodoo there eh?
Mentioned a whole lot of issues regarding this company. Didn’t want to try and respond to any of that. That’s just scratching the surface. Endless amount of gaffs from the goon squad. No voodoo there. Or do you rely solely on charts.
Your chart includes data after the fact. You need to show a chart before Dday on Oct 29 of last year. Pretty useless without.
You should go back and check EichKings predictions from a long while back. Spot on. No chart necessary. Even Allow had to admit how spot on they were. Done all without charts. Not to take away from his insights, but with the twins in charge, it was pretty much inevitable.
Wasn’t there talk of $1.20 resistance and if broken would be a quick fall under a buck. We broke through so you would have thought they would sell. But they added more on the last nickel run, which will still be under water after today. I’m going to wait until close, then watch where I should have sold or bought.
LMBO!!! You would have sold them. Sure you would have. Right at the absolute top I bet. Hindsight is 20/20. I think, I think, I think...I’m a BELIEBER!!!! Care to provide a chart right before Dday of last year to prove it? Too funny.
What’s the chart showing about today’s news? What’s your prediction on the price today? tomorrow? Next week? Next month? Let me guess. Wait until then.
Hey EichKing,
Sadly I never left. Have unfortunately read every post. After the clowns were voted in with ease, I said I’d limit my postings. But a couple of people on this board, constantly have absolutely zero concern with anything, but are so proud of their “big buys” at much higher prices. Somehow think it’s brilliant. Yet they’re the first to criticize long timers for investing too early. Seems they’d be down way more than I would ever be. And they did it in a year and a half. That’s the definition of brilliant. As long as Tobias is in, I’m Happy. Seems to have a thing for the black red and gold eh. Wie geht’s.
And now we have a chart lover on board. Too bad they didn’t come across Pluristem one year earlier. Would have thrown the farm at this stock in the pump of 2017. Charts would have been a screaming buy, only to get a 2x4 to the knees when the reason came out. Jokes.
They’re all excited now about Thermo too. Got their hands on this technology 11 years ago...when it was in its infancy. Said this last year that they blew this huge opportunity to be the leaders in manufacturing of cells. Now do a search of bioreactors, 3D bioreactors, single use, 1000L, 2000L. They’re everywhere. Little late to the party. Would have been great to see a guy from Thermo be interviewed about the relationship. Kaki’s words mean jack.
But like always from the goons, be as vague as possible, and keep the shareholders guessing. Just like their inability to do a cc or the absolute joke of something they call a shareholder update. Absolutely laughable, with zero information whatsoever in it. Remember though...they made most milestones.
Where’s the trial enrolment update? Have we ever got one ever. Oh ya, after the IC trial seemed like it had been forgotten about for a couple of years. Have a look at Brainstorm. Every chance they get, they release how their enrolment is moving along. We get crickets. Coincidental, or is enrolment chugging along at a pace similar to IC...pathetic. Fingers crossed for 2018 still Allo.
But hey, the had a PR last year that they want get 40 sites up and running by the end of 2017. In the final quarter of 2018, and still sitting at 39 sites. One more to go and you can celebrate another big milestone made.
Or how about waiting for interim results from HCT. Wow what a delay on that one huh. 2h17 was the date for that one. Along with NYBC. Crickets.
And yes the forgotten ODD’s we got. Preeclampsia steering committee was formed for what? Those guys probably joined for free huh. But the twins are competent and deserved those huge bonuses.
And ARS. Contract talks broke down? Still expecting a contract in 2h17? Now it’s because the order is too big for us to handle. Or we need a thawing device before it’s a go. Didn’t Zami invent one? But but but we’ve been paying quite a few bucks I’d imagine, for our state of the art facility. Didn’t they even expand it a few years ago. Great call guys. Smart businessmen is what we have here. We should just manufacture as many doses as we can regardless of the cost. Who cares if it’s not approved yet. Just do it guys. Feel big...strong...just like bull. Top secret for sure. Almost 18 months since pivotal trial ended. No need for concern though. Heard the NHP union voted to strike last year.
Funny though that they are trying to do some sort of manufacturing deal. Or how about the drastic reduction in shoes this year. You’re not reading these posts here are you Kaki and Quackie.
It’s funny that I stopped posting for quite a period of time, but the same unanswered questions remain, as if I’m stuck in a time warp. Miss after miss, unwarranted bonus after bonus. Some things never change. Except the downtrend in our price. Don’t need any chart to show me that. It’s the one thing the twins do best.
But have zero concerns whatsoever. It’s all good. Tobias says so and he gets paid consulting fees.
You know what? Our original twin gets paid via consulting fees. Too bad when that job was posted it came with a no experience necessary clause. Now we have a mini me accountant too. And people wonder why our price is where it is. Controller. Too funny.
And what term would you call someone who posts they’re down “minimally” when “big” trades were made around $2. Bragged about it too. Several 25k blocks remember. They even coined the phrase “anything under $2 is a deal”. Or “I don’t even know what my account is at”. How close you make it to 200k shares? But like Advaxis, the lower it goes, the better the deal. Buy at the top and average down. BRILLIANT. LMBO